Literature DB >> 16928389

Australian venomous jellyfish, envenomation syndromes, toxins and therapy.

James Tibballs1.   

Abstract

The seas and oceans around Australia harbour numerous venomous jellyfish. Chironex fleckeri, the box jellyfish, is the most lethal causing rapid cardiorespiratory depression and although its venom has been characterised, its toxins remain to be identified. A moderately effective antivenom exists which is also partially effective against another chirodropid, Chiropsalmus sp. Numerous carybdeids, some unidentified, cause less severe illness, including Carybdea rastoni whose toxins CrTX-A and CrTX-B are large proteins. Carukia barnesi, another small carybdeid is one cause of the 'Irukandji' syndrome which includes delayed pain from severe muscle cramping, vomiting, anxiety, restlessness, sweating and prostration, and occasionally severe hypertension and acute cardiac failure. The syndrome is in part caused by release of catecholamines but the cause of heart failure is undefined. The venom contains a sodium channel modulator. Two species of Physalia are present and although one is potentially lethal, has not caused death in Australian waters. Other significant genera of jellyfish include Tamoya, Pelagia, Cyanea, Aurelia and Chyrosaora.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16928389     DOI: 10.1016/j.toxicon.2006.07.020

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  40 in total

1.  Nematocytes' activation in Pelagia noctiluca (Cnidaria, Scyphozoa) oral arms.

Authors:  R Morabito; A Marino; G La Spada
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2012-04-20       Impact factor: 1.836

Review 2.  [Jellyfish sting injuries].

Authors:  D Mebs
Journal:  Hautarzt       Date:  2014-10       Impact factor: 0.751

3.  Severe fundus lesions induced by ocular jellyfish stings: A case report.

Authors:  Xiang-Yue Zheng; De-Jin Cheng; Li-Hua Lian; Ru-Ting Zhang; Xiao-Yi Yu
Journal:  World J Clin Cases       Date:  2020-10-06       Impact factor: 1.337

4.  Lion's mane jellyfish (Cyanea capillata) envenoming presenting as suspected decompression sickness.

Authors:  Andrew Trevett; Carolyn Sheehan; Antony Wilkinson; Inez Moss
Journal:  Diving Hyperb Med       Date:  2019-03-31       Impact factor: 0.887

Review 5.  Immunological and toxinological responses to jellyfish stings.

Authors:  James Tibballs; Angel A Yanagihara; Helen C Turner; Ken Winkel
Journal:  Inflamm Allergy Drug Targets       Date:  2011-10

6.  Neurotoxin localization to ectodermal gland cells uncovers an alternative mechanism of venom delivery in sea anemones.

Authors:  Yehu Moran; Grigory Genikhovich; Dalia Gordon; Stefanie Wienkoop; Claudia Zenkert; Suat Ozbek; Ulrich Technau; Michael Gurevitz
Journal:  Proc Biol Sci       Date:  2011-11-02       Impact factor: 5.349

7.  Analysis of Pelagia noctiluca proteome Reveals a Red Fluorescent Protein, a Zinc Metalloproteinase and a Peroxiredoxin.

Authors:  Bárbara Frazão; Alexandre Campos; Hugo Osório; Benjamin Thomas; Sérgio Leandro; Alexandre Teixeira; Vitor Vasconcelos; Agostinho Antunes
Journal:  Protein J       Date:  2017-04       Impact factor: 2.371

8.  Proteomic Changes during the Dermal Toxicity Induced by Nemopilema nomurai Jellyfish Venom in HaCaT Human Keratinocyte.

Authors:  Indu Choudhary; Duhyeon Hwang; Jinho Chae; Wonduk Yoon; Changkeun Kang; Euikyung Kim
Journal:  Toxins (Basel)       Date:  2021-04-27       Impact factor: 4.546

Review 9.  Immunological Responses to Envenomation.

Authors:  Rachael Y M Ryan; Jamie Seymour; Alex Loukas; J Alejandro Lopez; Maria P Ikonomopoulou; John J Miles
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

10.  Cardiovascular effect is independent of hemolytic toxicity of tentacle-only extract from the jellyfish Cyanea capillata.

Authors:  Xiao Liang; Wang Beilei; Li Ying; Wang Qianqian; Liu Sihua; Wang Yang; Liu Guoyan; Lu Jia; Ye Xuting; Zhang Liming
Journal:  PLoS One       Date:  2012-08-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.